Knight Cancer signal achievements of 2022
People at the Knight Cancer Institute accomplished a lot in 2022. Through innovative, collaborative research and education, the institute delivers cancer prevention, detection, and care — one...
Tag: experimental therapeutics
OHSU scientists represent at AACR
A Knight Cancer Institute scientist took the reins as president of the American Association for Cancer Research. Another joined the prestigious ranks of AACR fellows. And a...
Expanding access to experimental cancer treatments in Oregon: Q&A with Shivaani Kummar
This week, the OHSU Knight Cancer Institute opened a new, 13,000-square-foot space devoted to serving patients taking part in early-phase clinical trials. The unit completes the build-out of the...
First-in-class drug targets resistant ovarian cancer
Cancer researchers have discovered a way to target a pivotal driver of drug resistance in ovarian cancer, one of the top causes of cancer death in women. The experimental compound, called SU056,...